Pharmacokinetics and dosage regimen of levoflfl oxacin in buffalo calves after single subcutaneous administration

Veterinarski Arhiv

Volumn 80, Issue 2, 2010, Pages 195-203

  Ram, Data ^a   Dumka, Vinod K ^a   Sandhu, Harpal S ^a   Raipuria, Mukesh ^a  

^a GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

Author keywords

Buffalo calves; Dosage; Levoflfl oxacin; Pharmacokinetics; Subcutaneous

Indexed keywords

EID: 77952020174     PISSN: 03725480     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ALIABADI, F. S., P. LEES (2001): Pharmacokinetics and pharmacodynamics of danofl oxacin in serum and tissue fl uids of goats following intravenous and intramuscular administration. Am. J. Vet. Res. 62, 1979-1989.
2. APLEY, M. D., D. W. UPSON (1993): Lung tissue concentrations and plasma pharmacokinetics of danofl oxacin in calves with acute pneumonia. Am. J. Vet. Res. 54, 937-943.
3. ARRET, B., D. P. JOHNSON, A. KIRSHBAUM (1971): Outline of details for microbiological assay of antibiotics: second revision. J. Pharm. Sci. 60, 1689-1694.
4. ATEF, M., A. Y. EL-GENDI, M. M. AZIZA AMER, M. ABD EL ATY (2001): Some pharmacokinetic data for danofl oxacin in healthy goats. Vet. Res. Commun. 25, 367-377.
5. BAGGOT, J. D. (1977): Principles of Drug Disposition in Domestic Animals: The Basis of Veterinary Clinical Pharmacokinetics, W.B. Saunders, Philadelphia.
6. BAKKEN, J. S. (2004): The fl uoroquinolones: how long will their utility last? Scand. J. Infect. Dis. 36, 85-92.
7. CHULAVATNATOL, S., B. CHINDAVIJAK, A. VIBHAGOOL, W. WANANUKUL, C. SRIAPHA, C. SIRISANGTRAGUL (1999): Pharmacokinetics of levofl oxacin in healthy Thai male volunteers. J. Med. Assoc. Thai. 82, 1127-1135.
8. DAVIS, R., H. M. BRYSON (1994): Levofl oxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic effi cacy. Drugs 47, 677-700.
9. DRAGO, L., E. DEVECCHI, B. MOMBELLI, L. NICOLA, M. VALLI, M. R. GISMONDO (2001): Activity of levofl oxacin and ciprofl oxacin against urinary pathogens. J. Antimicrob. Chemother. 48, 37-45.
10. DUGGIRALA, A., J. JOSEPH, S. SHARMA, R. NUTHETI, P. GARG, T. DAS (2007): Activity of newer fl uoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: An in vitro comparison. Ind. J. Ophthalmol. 55, 5-6.
11. DUMKA, V. K. (2007): Disposition kinetics and dosage regimen of levofl oxacin on concomitant administration with paracetamol in cross bred calves. J. Vet. Sci. 8, 357-360.
12. DUMKA, V. K., A. K. SRIVASTAVA (2006): Pharmacokinetics, urinary excretion and dosage regimen of levofl oxacin following single intramuscular administration in cross bred calves. J. Vet. Sci. 7, 333-337.
13. DUMKA, V. K., A. K. SRIVASTAVA (2007a): Disposition kinetics, urinary excretion and dosage regimen of levofl oxacin formulation following single intravenous administration in cross bred calves. Vet. Res. Commun. 31, 873-879.
14. DUMKA, V. K., A. K. SRIVASTAVA (2007b): Kinetic disposition, urinary excretion and dosage regimen of subcutaneously administered levofl oxacin in cross bred calves. Iranian J. Vet. Res. 8, 313-318.
15. DUMKA, V. K., H. SINGH, A. K. SRIVASTAVA (2008) Disposition kinetics and urinary excretion of levofl oxacin on concomitant administration with meloxicam in cross bred calves. Environ. Toxicol. Pharmacol. 26, 56-60.
16. EDELSTEIN, P. H., M. A. EDELSTEIN, K. H. LEHR, J. REN (1996): In vitro activity of levofl oxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. J. Antimicrob. Chemother. 37, 117-126.
17. GIBALDI, M., D. PERRIER (1982): Pharmacokinetics, 2nd ed. Marcel Dekker Inc. New York.
18. GIPS, M., S. SOBACK (1996): Norfl oxacin nicotinate pharmacokinetics in unweaned and weaned calves. J. Vet. Pharmacol. Ther. 19, 130-134.
19. GRIFFITH, D. C., E. CORCORAN, D. LOFLAND, A. LEE, D. CHO, O. LOMOVSKAYA, M. N. DUDLEY (2006): Pharmacodynamics of levofl oxacin against Pseudomonas aeruginosa with reduced susceptibility due to different effl ux pumps: do elevated MICs always predict reduced in vivo effi cacy? Antimicrob. Agents Chemother. 50, 1628-1632.
20. HO, P. L., K. H. CHOW, G. C. MAK, K. W. TSANG, Y. L. LAU, A. Y. HO, E. L. LAI, S. S. CHIU (2004): Decreased levofl oxacin susceptibility in Haemophilus infl uenzae in children, Hong Kong Emer. Infect. Dis. 10, 1960-1962.
21. KLESEL, N., K. H. GEWENIGER, P. KOLETZKI, D. ISERT, M. LIMBERT, A. MARKUS, G. RIESS, H. SCHRAMM, P. IYER (1995): Chemotherapeutic activity of levofl oxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. J. Antimicrob. Chemother. 35, 805-819.
22. LANGTRY, H. D., H. M. LAMB (1998): Levofl oxacin: its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs 56, 487-515.
23. McKELLAR, Q., I. GIBSON, A. MONTERIO, M. BREGANTE (1999): Pharmacokinetics of enrofl oxacin and danofl oxacin in plasma, infl ammatory exudates and bronchial secretions of calves following subcutaneous administration. Antimicrob. Agents Chemother. 43, 1988-1992.
24. NORTH, D. S., D. N. FISH, J. J. REDINGTON (1998): Levofl oxacin, a second-generation fl uoroquinolone. Pharmacotherapy 18, 915-935.
25. RAIPURIA, M., V. K. DUMKA, H. S. SANDHU, D. RAM (2006): Gatifl oxacin pharmacokinetics in buffalo calves after single intramuscular administration. Vet. Arhiv. 76, 471-478.
26. RAIPURIA, M., V. K. DUMKA, H. S. SANDHU, D. RAM (2007): Dosage regimen of gatifl oxacin following single subcutaneous administration in buffalo calves (Bubalus bubalis). Ind. J. Vet. Med. 27, 5-9.
27. RAM, D., V. K. DUMKA, S. K. SHARMA, H. S. SANDHU (2008): Intramuscular pharmacokinetics, dosage regimen and in vitro plasma protein binding of levofl oxacin in buffalo calves. Iranian J. Vet. Res. 9, 121-126.
28. SCHNEIDER, M., M. VALLE, F. WOEHRLE, B. BOISRAME (2004): Pharmacokinetics of marbofl oxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. J. Dairy Sci. 87, 202-211.
29. SHEM-TOV, M., G. ZIV, A. GLICKMAN, A. SARAN (1997): Pharmacokinetics and penetration of marbofl oxacin from blood into milk of cows and ewes. J. Vet. Med. Assoc. 44, 511-519. (Pubitemid 127525000)